|
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda
|
Ngabonziza, J. S.; Habimana, Y. M.; Decroo, T.; Migambi, P.; Dushime, A.; Mazarati, J. B.; Rigouts, L.; Affolabi, D.; Ivan, E.; Meehan, C. J.; Van Deun, A.; Fissette, K.; Habiyambere, I.; Nyaruhirira, A. U.; Turate, I.; Semahore, J. M.; Ndjeka, N.; Muvunyi, C. M.; Condo, J. U.; Gasana, M.; Hasker, E.; Torrea, G.; de Jong, B. C.
|
International Journal of Tuberculosis and Lung Disease |
2020
|
Article
|
|
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide
|
Ngabonziza, J. C. S.; Diallo, A. B.; Tagliani, E.; Diarra, B.; Kadanga, A. E.; Togo, A. C. G.; Thiam, A.; de Rijk, W. B.; Alagna, R.; Houeto, S.; Ba, F.; Dagnra, A. Y.; Ivan, E.; Affolabi, D.; Schwoebel, V.; Trebucq, A.; de Jong, B. C.; Rigouts, L.; Daneau, G.
|
PLoS ONE |
2017
|
Article-E
|